Clinical Trial Update: To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study to assess the relative bioavailability of cetirizine hydrochloride/pseudoephedrine hydrochloride extended-release tablets under fasting conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Cetirizine hydrochloride/pseudoephedrine hydrochloride extended-release tablets (cetirizine hydrochloride; pseudoephedrine hydrochloride)

Snippet

Sponsor: Sandoz | Conditions: Allergies | Phase 1 | Status: COMPLETED